nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—PTGS1—kidney cancer	0.404	1	CbGaD
Eszopiclone—CYP3A4—Everolimus—kidney cancer	0.0431	0.135	CbGbCtD
Eszopiclone—CYP2C8—Pazopanib—kidney cancer	0.0377	0.118	CbGbCtD
Eszopiclone—CYP3A4—Temsirolimus—kidney cancer	0.0291	0.0915	CbGbCtD
Eszopiclone—CYP2C9—Capecitabine—kidney cancer	0.0274	0.0862	CbGbCtD
Eszopiclone—CYP2C8—Erlotinib—kidney cancer	0.0269	0.0846	CbGbCtD
Eszopiclone—CYP2C8—Paclitaxel—kidney cancer	0.0246	0.0774	CbGbCtD
Eszopiclone—CYP2C8—Sorafenib—kidney cancer	0.0219	0.0687	CbGbCtD
Eszopiclone—CYP2C9—Paclitaxel—kidney cancer	0.0172	0.054	CbGbCtD
Eszopiclone—CYP3A4—Pazopanib—kidney cancer	0.0153	0.0481	CbGbCtD
Eszopiclone—CYP2C9—Sorafenib—kidney cancer	0.0153	0.048	CbGbCtD
Eszopiclone—CYP3A4—Erlotinib—kidney cancer	0.0109	0.0343	CbGbCtD
Eszopiclone—CYP3A4—Paclitaxel—kidney cancer	0.00999	0.0314	CbGbCtD
Eszopiclone—CYP3A4—Sorafenib—kidney cancer	0.00887	0.0279	CbGbCtD
Eszopiclone—CYP3A4—Vinblastine—kidney cancer	0.00876	0.0275	CbGbCtD
Eszopiclone—CYP3A4—Vincristine—kidney cancer	0.00861	0.0271	CbGbCtD
Eszopiclone—CYP3A4—Sunitinib—kidney cancer	0.00719	0.0226	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—kidney cancer	0.00538	0.0169	CbGbCtD
Eszopiclone—Zopiclone—PTGS1—kidney cancer	0.00307	1	CrCbGaD
Eszopiclone—Malaise—Paclitaxel—kidney cancer	0.000128	0.000515	CcSEcCtD
Eszopiclone—Vertigo—Paclitaxel—kidney cancer	0.000128	0.000513	CcSEcCtD
Eszopiclone—Hypersensitivity—Sunitinib—kidney cancer	0.000127	0.000511	CcSEcCtD
Eszopiclone—Decreased appetite—Vincristine—kidney cancer	0.000127	0.00051	CcSEcCtD
Eszopiclone—Pruritus—Sorafenib—kidney cancer	0.000127	0.00051	CcSEcCtD
Eszopiclone—Vomiting—Erlotinib—kidney cancer	0.000127	0.00051	CcSEcCtD
Eszopiclone—Erythema multiforme—Capecitabine—kidney cancer	0.000127	0.000509	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000126	0.000507	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000126	0.000507	CcSEcCtD
Eszopiclone—Fatigue—Vincristine—kidney cancer	0.000126	0.000506	CcSEcCtD
Eszopiclone—Rash—Erlotinib—kidney cancer	0.000126	0.000505	CcSEcCtD
Eszopiclone—Dermatitis—Erlotinib—kidney cancer	0.000126	0.000505	CcSEcCtD
Eszopiclone—Palpitations—Paclitaxel—kidney cancer	0.000126	0.000505	CcSEcCtD
Eszopiclone—Insomnia—Gemcitabine—kidney cancer	0.000126	0.000504	CcSEcCtD
Eszopiclone—Headache—Erlotinib—kidney cancer	0.000125	0.000502	CcSEcCtD
Eszopiclone—Tinnitus—Capecitabine—kidney cancer	0.000125	0.000502	CcSEcCtD
Eszopiclone—Constipation—Vincristine—kidney cancer	0.000125	0.000502	CcSEcCtD
Eszopiclone—Pain—Vincristine—kidney cancer	0.000125	0.000502	CcSEcCtD
Eszopiclone—Osteoarthritis—Doxorubicin—kidney cancer	0.000125	0.000502	CcSEcCtD
Eszopiclone—Diplopia—Doxorubicin—kidney cancer	0.000125	0.000502	CcSEcCtD
Eszopiclone—Paraesthesia—Gemcitabine—kidney cancer	0.000125	0.0005	CcSEcCtD
Eszopiclone—Asthenia—Sunitinib—kidney cancer	0.000124	0.000498	CcSEcCtD
Eszopiclone—Dyspnoea—Gemcitabine—kidney cancer	0.000124	0.000496	CcSEcCtD
Eszopiclone—Nausea—Vinblastine—kidney cancer	0.000123	0.000495	CcSEcCtD
Eszopiclone—Somnolence—Gemcitabine—kidney cancer	0.000123	0.000495	CcSEcCtD
Eszopiclone—Convulsion—Paclitaxel—kidney cancer	0.000123	0.000495	CcSEcCtD
Eszopiclone—Migraine—Doxorubicin—kidney cancer	0.000123	0.000494	CcSEcCtD
Eszopiclone—Affect lability—Doxorubicin—kidney cancer	0.000123	0.000494	CcSEcCtD
Eszopiclone—Nausea—Everolimus—kidney cancer	0.000123	0.000493	CcSEcCtD
Eszopiclone—Diarrhoea—Sorafenib—kidney cancer	0.000123	0.000493	CcSEcCtD
Eszopiclone—Hypertension—Paclitaxel—kidney cancer	0.000123	0.000493	CcSEcCtD
Eszopiclone—Pruritus—Sunitinib—kidney cancer	0.000122	0.000491	CcSEcCtD
Eszopiclone—Myalgia—Paclitaxel—kidney cancer	0.000121	0.000486	CcSEcCtD
Eszopiclone—Chest pain—Paclitaxel—kidney cancer	0.000121	0.000486	CcSEcCtD
Eszopiclone—Anxiety—Paclitaxel—kidney cancer	0.000121	0.000485	CcSEcCtD
Eszopiclone—Face oedema—Doxorubicin—kidney cancer	0.000121	0.000484	CcSEcCtD
Eszopiclone—Decreased appetite—Gemcitabine—kidney cancer	0.000121	0.000484	CcSEcCtD
Eszopiclone—Hypersensitivity—Dactinomycin—kidney cancer	0.000121	0.000484	CcSEcCtD
Eszopiclone—Chills—Capecitabine—kidney cancer	0.00012	0.000483	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00012	0.000481	CcSEcCtD
Eszopiclone—Discomfort—Paclitaxel—kidney cancer	0.00012	0.00048	CcSEcCtD
Eszopiclone—Fatigue—Gemcitabine—kidney cancer	0.00012	0.00048	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Vincristine—kidney cancer	0.00012	0.00048	CcSEcCtD
Eszopiclone—Dizziness—Sorafenib—kidney cancer	0.000119	0.000477	CcSEcCtD
Eszopiclone—Pain—Gemcitabine—kidney cancer	0.000119	0.000476	CcSEcCtD
Eszopiclone—Constipation—Gemcitabine—kidney cancer	0.000119	0.000476	CcSEcCtD
Eszopiclone—Nausea—Erlotinib—kidney cancer	0.000119	0.000476	CcSEcCtD
Eszopiclone—Alopecia—Capecitabine—kidney cancer	0.000119	0.000476	CcSEcCtD
Eszopiclone—Dry mouth—Paclitaxel—kidney cancer	0.000119	0.000476	CcSEcCtD
Eszopiclone—Mood swings—Doxorubicin—kidney cancer	0.000118	0.000475	CcSEcCtD
Eszopiclone—Diarrhoea—Sunitinib—kidney cancer	0.000118	0.000475	CcSEcCtD
Eszopiclone—Ataxia—Doxorubicin—kidney cancer	0.000118	0.000472	CcSEcCtD
Eszopiclone—Asthenia—Dactinomycin—kidney cancer	0.000117	0.000471	CcSEcCtD
Eszopiclone—Confusional state—Paclitaxel—kidney cancer	0.000117	0.00047	CcSEcCtD
Eszopiclone—Dehydration—Doxorubicin—kidney cancer	0.000116	0.000467	CcSEcCtD
Eszopiclone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000116	0.000466	CcSEcCtD
Eszopiclone—Abdominal pain—Vincristine—kidney cancer	0.000116	0.000464	CcSEcCtD
Eszopiclone—Body temperature increased—Vincristine—kidney cancer	0.000116	0.000464	CcSEcCtD
Eszopiclone—Infection—Paclitaxel—kidney cancer	0.000115	0.000463	CcSEcCtD
Eszopiclone—Dry skin—Doxorubicin—kidney cancer	0.000115	0.00046	CcSEcCtD
Eszopiclone—Dysgeusia—Capecitabine—kidney cancer	0.000114	0.000459	CcSEcCtD
Eszopiclone—Dizziness—Sunitinib—kidney cancer	0.000114	0.000459	CcSEcCtD
Eszopiclone—Feeling abnormal—Gemcitabine—kidney cancer	0.000114	0.000459	CcSEcCtD
Eszopiclone—Vomiting—Sorafenib—kidney cancer	0.000114	0.000458	CcSEcCtD
Eszopiclone—Hypokalaemia—Doxorubicin—kidney cancer	0.000114	0.000457	CcSEcCtD
Eszopiclone—Tachycardia—Paclitaxel—kidney cancer	0.000113	0.000455	CcSEcCtD
Eszopiclone—Rash—Sorafenib—kidney cancer	0.000113	0.000455	CcSEcCtD
Eszopiclone—Dermatitis—Sorafenib—kidney cancer	0.000113	0.000454	CcSEcCtD
Eszopiclone—Back pain—Capecitabine—kidney cancer	0.000113	0.000453	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000113	0.000452	CcSEcCtD
Eszopiclone—Headache—Sorafenib—kidney cancer	0.000113	0.000452	CcSEcCtD
Eszopiclone—Muscle spasms—Capecitabine—kidney cancer	0.000112	0.000451	CcSEcCtD
Eszopiclone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000112	0.000451	CcSEcCtD
Eszopiclone—Diarrhoea—Dactinomycin—kidney cancer	0.000112	0.000449	CcSEcCtD
Eszopiclone—Anorexia—Paclitaxel—kidney cancer	0.000111	0.000444	CcSEcCtD
Eszopiclone—Gastritis—Doxorubicin—kidney cancer	0.000111	0.000444	CcSEcCtD
Eszopiclone—Muscular weakness—Doxorubicin—kidney cancer	0.00011	0.000442	CcSEcCtD
Eszopiclone—Vision blurred—Capecitabine—kidney cancer	0.00011	0.000442	CcSEcCtD
Eszopiclone—Vomiting—Sunitinib—kidney cancer	0.00011	0.000441	CcSEcCtD
Eszopiclone—Body temperature increased—Gemcitabine—kidney cancer	0.00011	0.00044	CcSEcCtD
Eszopiclone—Tremor—Capecitabine—kidney cancer	0.000109	0.000439	CcSEcCtD
Eszopiclone—Rash—Sunitinib—kidney cancer	0.000109	0.000437	CcSEcCtD
Eszopiclone—Dermatitis—Sunitinib—kidney cancer	0.000109	0.000437	CcSEcCtD
Eszopiclone—Ill-defined disorder—Capecitabine—kidney cancer	0.000108	0.000435	CcSEcCtD
Eszopiclone—Headache—Sunitinib—kidney cancer	0.000108	0.000435	CcSEcCtD
Eszopiclone—Asthma—Doxorubicin—kidney cancer	0.000108	0.000434	CcSEcCtD
Eszopiclone—Influenza—Doxorubicin—kidney cancer	0.000108	0.000434	CcSEcCtD
Eszopiclone—Dysphagia—Doxorubicin—kidney cancer	0.000108	0.000434	CcSEcCtD
Eszopiclone—Anaemia—Capecitabine—kidney cancer	0.000108	0.000433	CcSEcCtD
Eszopiclone—Hypersensitivity—Vincristine—kidney cancer	0.000108	0.000432	CcSEcCtD
Eszopiclone—Nausea—Sorafenib—kidney cancer	0.000107	0.000428	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000106	0.000425	CcSEcCtD
Eszopiclone—Malaise—Capecitabine—kidney cancer	0.000105	0.000423	CcSEcCtD
Eszopiclone—Insomnia—Paclitaxel—kidney cancer	0.000105	0.000422	CcSEcCtD
Eszopiclone—Vertigo—Capecitabine—kidney cancer	0.000105	0.000421	CcSEcCtD
Eszopiclone—Asthenia—Vincristine—kidney cancer	0.000105	0.000421	CcSEcCtD
Eszopiclone—Paraesthesia—Paclitaxel—kidney cancer	0.000104	0.000419	CcSEcCtD
Eszopiclone—Vomiting—Dactinomycin—kidney cancer	0.000104	0.000418	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—kidney cancer	0.000104	0.000417	CcSEcCtD
Eszopiclone—Dyspnoea—Paclitaxel—kidney cancer	0.000104	0.000416	CcSEcCtD
Eszopiclone—Somnolence—Paclitaxel—kidney cancer	0.000103	0.000414	CcSEcCtD
Eszopiclone—Palpitations—Capecitabine—kidney cancer	0.000103	0.000414	CcSEcCtD
Eszopiclone—Rash—Dactinomycin—kidney cancer	0.000103	0.000414	CcSEcCtD
Eszopiclone—Nausea—Sunitinib—kidney cancer	0.000103	0.000412	CcSEcCtD
Eszopiclone—Dyspepsia—Paclitaxel—kidney cancer	0.000102	0.00041	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—kidney cancer	0.000101	0.000405	CcSEcCtD
Eszopiclone—Decreased appetite—Paclitaxel—kidney cancer	0.000101	0.000405	CcSEcCtD
Eszopiclone—Hypertension—Capecitabine—kidney cancer	0.000101	0.000405	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.0001	0.000402	CcSEcCtD
Eszopiclone—Fatigue—Paclitaxel—kidney cancer	0.0001	0.000402	CcSEcCtD
Eszopiclone—Diarrhoea—Vincristine—kidney cancer	0.0001	0.000402	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—kidney cancer	9.98e-05	0.000401	CcSEcCtD
Eszopiclone—Asthenia—Gemcitabine—kidney cancer	9.96e-05	0.000399	CcSEcCtD
Eszopiclone—Myalgia—Capecitabine—kidney cancer	9.95e-05	0.000399	CcSEcCtD
Eszopiclone—Chest pain—Capecitabine—kidney cancer	9.95e-05	0.000399	CcSEcCtD
Eszopiclone—Constipation—Paclitaxel—kidney cancer	9.94e-05	0.000399	CcSEcCtD
Eszopiclone—Pain—Paclitaxel—kidney cancer	9.94e-05	0.000399	CcSEcCtD
Eszopiclone—Anxiety—Capecitabine—kidney cancer	9.91e-05	0.000398	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—kidney cancer	9.87e-05	0.000396	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—kidney cancer	9.84e-05	0.000395	CcSEcCtD
Eszopiclone—Discomfort—Capecitabine—kidney cancer	9.83e-05	0.000394	CcSEcCtD
Eszopiclone—Pruritus—Gemcitabine—kidney cancer	9.82e-05	0.000394	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—kidney cancer	9.78e-05	0.000392	CcSEcCtD
Eszopiclone—Dry mouth—Capecitabine—kidney cancer	9.73e-05	0.00039	CcSEcCtD
Eszopiclone—Nausea—Dactinomycin—kidney cancer	9.73e-05	0.00039	CcSEcCtD
Eszopiclone—Dizziness—Vincristine—kidney cancer	9.67e-05	0.000388	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—kidney cancer	9.64e-05	0.000387	CcSEcCtD
Eszopiclone—Confusional state—Capecitabine—kidney cancer	9.61e-05	0.000386	CcSEcCtD
Eszopiclone—Feeling abnormal—Paclitaxel—kidney cancer	9.57e-05	0.000384	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Paclitaxel—kidney cancer	9.5e-05	0.000381	CcSEcCtD
Eszopiclone—Diarrhoea—Gemcitabine—kidney cancer	9.49e-05	0.000381	CcSEcCtD
Eszopiclone—Infection—Capecitabine—kidney cancer	9.47e-05	0.00038	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Doxorubicin—kidney cancer	9.45e-05	0.000379	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—kidney cancer	9.39e-05	0.000377	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—kidney cancer	9.37e-05	0.000376	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—kidney cancer	9.37e-05	0.000376	CcSEcCtD
Eszopiclone—Tachycardia—Capecitabine—kidney cancer	9.31e-05	0.000373	CcSEcCtD
Eszopiclone—Vomiting—Vincristine—kidney cancer	9.3e-05	0.000373	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—kidney cancer	9.24e-05	0.000371	CcSEcCtD
Eszopiclone—Urticaria—Paclitaxel—kidney cancer	9.23e-05	0.00037	CcSEcCtD
Eszopiclone—Rash—Vincristine—kidney cancer	9.22e-05	0.00037	CcSEcCtD
Eszopiclone—Hyperhidrosis—Capecitabine—kidney cancer	9.22e-05	0.00037	CcSEcCtD
Eszopiclone—Dermatitis—Vincristine—kidney cancer	9.21e-05	0.00037	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—kidney cancer	9.19e-05	0.000369	CcSEcCtD
Eszopiclone—Body temperature increased—Paclitaxel—kidney cancer	9.18e-05	0.000368	CcSEcCtD
Eszopiclone—Abdominal pain—Paclitaxel—kidney cancer	9.18e-05	0.000368	CcSEcCtD
Eszopiclone—Headache—Vincristine—kidney cancer	9.16e-05	0.000368	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—kidney cancer	9.09e-05	0.000365	CcSEcCtD
Eszopiclone—Anorexia—Capecitabine—kidney cancer	9.09e-05	0.000365	CcSEcCtD
Eszopiclone—Vomiting—Gemcitabine—kidney cancer	8.82e-05	0.000354	CcSEcCtD
Eszopiclone—Rash—Gemcitabine—kidney cancer	8.75e-05	0.000351	CcSEcCtD
Eszopiclone—Dermatitis—Gemcitabine—kidney cancer	8.74e-05	0.000351	CcSEcCtD
Eszopiclone—Headache—Gemcitabine—kidney cancer	8.69e-05	0.000349	CcSEcCtD
Eszopiclone—Nausea—Vincristine—kidney cancer	8.69e-05	0.000349	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.69e-05	0.000348	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—kidney cancer	8.67e-05	0.000348	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—kidney cancer	8.65e-05	0.000347	CcSEcCtD
Eszopiclone—Insomnia—Capecitabine—kidney cancer	8.62e-05	0.000346	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—kidney cancer	8.61e-05	0.000345	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—kidney cancer	8.59e-05	0.000344	CcSEcCtD
Eszopiclone—Paraesthesia—Capecitabine—kidney cancer	8.56e-05	0.000343	CcSEcCtD
Eszopiclone—Hypersensitivity—Paclitaxel—kidney cancer	8.56e-05	0.000343	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—kidney cancer	8.52e-05	0.000342	CcSEcCtD
Eszopiclone—Dyspnoea—Capecitabine—kidney cancer	8.5e-05	0.000341	CcSEcCtD
Eszopiclone—Dyspepsia—Capecitabine—kidney cancer	8.39e-05	0.000337	CcSEcCtD
Eszopiclone—Asthenia—Paclitaxel—kidney cancer	8.34e-05	0.000334	CcSEcCtD
Eszopiclone—Decreased appetite—Capecitabine—kidney cancer	8.29e-05	0.000333	CcSEcCtD
Eszopiclone—Nausea—Gemcitabine—kidney cancer	8.24e-05	0.000331	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Capecitabine—kidney cancer	8.23e-05	0.00033	CcSEcCtD
Eszopiclone—Fatigue—Capecitabine—kidney cancer	8.22e-05	0.00033	CcSEcCtD
Eszopiclone—Pruritus—Paclitaxel—kidney cancer	8.22e-05	0.00033	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—kidney cancer	8.18e-05	0.000328	CcSEcCtD
Eszopiclone—Constipation—Capecitabine—kidney cancer	8.15e-05	0.000327	CcSEcCtD
Eszopiclone—Pain—Capecitabine—kidney cancer	8.15e-05	0.000327	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—kidney cancer	8.07e-05	0.000324	CcSEcCtD
Eszopiclone—Diarrhoea—Paclitaxel—kidney cancer	7.95e-05	0.000319	CcSEcCtD
Eszopiclone—Feeling abnormal—Capecitabine—kidney cancer	7.86e-05	0.000315	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Capecitabine—kidney cancer	7.8e-05	0.000313	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—kidney cancer	7.76e-05	0.000311	CcSEcCtD
Eszopiclone—Dizziness—Paclitaxel—kidney cancer	7.68e-05	0.000308	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—kidney cancer	7.64e-05	0.000307	CcSEcCtD
Eszopiclone—Urticaria—Capecitabine—kidney cancer	7.57e-05	0.000304	CcSEcCtD
Eszopiclone—Body temperature increased—Capecitabine—kidney cancer	7.54e-05	0.000302	CcSEcCtD
Eszopiclone—Abdominal pain—Capecitabine—kidney cancer	7.54e-05	0.000302	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—kidney cancer	7.39e-05	0.000296	CcSEcCtD
Eszopiclone—Vomiting—Paclitaxel—kidney cancer	7.39e-05	0.000296	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—kidney cancer	7.37e-05	0.000296	CcSEcCtD
Eszopiclone—Rash—Paclitaxel—kidney cancer	7.33e-05	0.000294	CcSEcCtD
Eszopiclone—Dermatitis—Paclitaxel—kidney cancer	7.32e-05	0.000294	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—kidney cancer	7.31e-05	0.000293	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—kidney cancer	7.28e-05	0.000292	CcSEcCtD
Eszopiclone—Headache—Paclitaxel—kidney cancer	7.28e-05	0.000292	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—kidney cancer	7.24e-05	0.00029	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—kidney cancer	7.1e-05	0.000285	CcSEcCtD
Eszopiclone—Hypersensitivity—Capecitabine—kidney cancer	7.02e-05	0.000282	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—kidney cancer	6.99e-05	0.00028	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—kidney cancer	6.96e-05	0.000279	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—kidney cancer	6.92e-05	0.000278	CcSEcCtD
Eszopiclone—Nausea—Paclitaxel—kidney cancer	6.9e-05	0.000277	CcSEcCtD
Eszopiclone—Asthenia—Capecitabine—kidney cancer	6.84e-05	0.000274	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—kidney cancer	6.79e-05	0.000272	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—kidney cancer	6.77e-05	0.000271	CcSEcCtD
Eszopiclone—Pruritus—Capecitabine—kidney cancer	6.75e-05	0.000271	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—kidney cancer	6.65e-05	0.000267	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—kidney cancer	6.52e-05	0.000262	CcSEcCtD
Eszopiclone—Diarrhoea—Capecitabine—kidney cancer	6.52e-05	0.000262	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—kidney cancer	6.5e-05	0.000261	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—kidney cancer	6.41e-05	0.000257	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—kidney cancer	6.41e-05	0.000257	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—kidney cancer	6.39e-05	0.000256	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—kidney cancer	6.33e-05	0.000254	CcSEcCtD
Eszopiclone—Dizziness—Capecitabine—kidney cancer	6.31e-05	0.000253	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—kidney cancer	6.27e-05	0.000252	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—kidney cancer	6.2e-05	0.000249	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—kidney cancer	6.15e-05	0.000247	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—kidney cancer	6.11e-05	0.000245	CcSEcCtD
Eszopiclone—Vomiting—Capecitabine—kidney cancer	6.06e-05	0.000243	CcSEcCtD
Eszopiclone—Rash—Capecitabine—kidney cancer	6.01e-05	0.000241	CcSEcCtD
Eszopiclone—Dermatitis—Capecitabine—kidney cancer	6.01e-05	0.000241	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—kidney cancer	6e-05	0.000241	CcSEcCtD
Eszopiclone—Headache—Capecitabine—kidney cancer	5.97e-05	0.00024	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—kidney cancer	5.94e-05	0.000238	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—kidney cancer	5.86e-05	0.000235	CcSEcCtD
Eszopiclone—Nausea—Capecitabine—kidney cancer	5.66e-05	0.000227	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.6e-05	0.000225	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—kidney cancer	5.56e-05	0.000223	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—kidney cancer	5.52e-05	0.000221	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—kidney cancer	5.48e-05	0.00022	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—kidney cancer	5.46e-05	0.000219	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—kidney cancer	5.41e-05	0.000217	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—kidney cancer	5.34e-05	0.000214	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.31e-05	0.000213	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—kidney cancer	5.3e-05	0.000213	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—kidney cancer	5.26e-05	0.000211	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—kidney cancer	5.26e-05	0.000211	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—kidney cancer	5.06e-05	0.000203	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—kidney cancer	5.03e-05	0.000202	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—kidney cancer	4.88e-05	0.000196	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—kidney cancer	4.86e-05	0.000195	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—kidney cancer	4.86e-05	0.000195	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—kidney cancer	4.53e-05	0.000182	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—kidney cancer	4.41e-05	0.000177	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—kidney cancer	4.35e-05	0.000174	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—kidney cancer	4.21e-05	0.000169	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—kidney cancer	4.06e-05	0.000163	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—kidney cancer	3.91e-05	0.000157	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—kidney cancer	3.88e-05	0.000155	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—kidney cancer	3.87e-05	0.000155	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—kidney cancer	3.85e-05	0.000154	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—kidney cancer	3.65e-05	0.000146	CcSEcCtD
Eszopiclone—GABRB2—Neuronal System—BRAF—kidney cancer	2.78e-05	0.00108	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	2.78e-05	0.00108	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.77e-05	0.00108	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.76e-05	0.00107	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—RAF1—kidney cancer	2.76e-05	0.00107	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.72e-05	0.00106	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.72e-05	0.00106	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—BRAF—kidney cancer	2.71e-05	0.00105	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTM1—kidney cancer	2.7e-05	0.00105	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.69e-05	0.00105	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.67e-05	0.00104	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	2.67e-05	0.00104	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—BRAF—kidney cancer	2.66e-05	0.00103	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.65e-05	0.00103	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.64e-05	0.00103	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.63e-05	0.00102	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.62e-05	0.00102	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—BRAF—kidney cancer	2.61e-05	0.00101	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.6e-05	0.00101	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.59e-05	0.00101	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	2.58e-05	0.001	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	2.56e-05	0.000996	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	2.56e-05	0.000996	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.56e-05	0.000995	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—BRAF—kidney cancer	2.55e-05	0.00099	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—RAF1—kidney cancer	2.54e-05	0.000988	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.53e-05	0.000984	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	2.53e-05	0.000983	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.52e-05	0.000981	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.47e-05	0.000961	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	2.43e-05	0.000943	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GLIPR1—kidney cancer	2.42e-05	0.00094	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PPAT—kidney cancer	2.42e-05	0.00094	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.42e-05	0.000939	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTP1—kidney cancer	2.39e-05	0.000931	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.39e-05	0.000928	CbGpPWpGaD
Eszopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.38e-05	0.000926	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	2.36e-05	0.000918	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—RAF1—kidney cancer	2.33e-05	0.000904	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.32e-05	0.0009	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.28e-05	0.000886	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.28e-05	0.000884	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—RAF1—kidney cancer	2.26e-05	0.000878	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	2.26e-05	0.000876	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ACY1—kidney cancer	2.25e-05	0.000876	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—FH—kidney cancer	2.25e-05	0.000874	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—APRT—kidney cancer	2.25e-05	0.000874	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.24e-05	0.00087	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—BRAF—kidney cancer	2.23e-05	0.000865	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—RAF1—kidney cancer	2.22e-05	0.000862	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.21e-05	0.00086	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.21e-05	0.000859	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.2e-05	0.000855	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.2e-05	0.000854	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—RAF1—kidney cancer	2.18e-05	0.000847	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.17e-05	0.000844	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.15e-05	0.000834	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.14e-05	0.00083	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—RAF1—kidney cancer	2.13e-05	0.000827	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GPC3—kidney cancer	2.12e-05	0.000822	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.11e-05	0.000819	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.09e-05	0.000811	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.08e-05	0.000809	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.07e-05	0.000805	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.06e-05	0.0008	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CA2—kidney cancer	2.06e-05	0.0008	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.02e-05	0.000786	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.02e-05	0.000785	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALAD—kidney cancer	2e-05	0.000779	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.99e-05	0.000772	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ST3GAL2—kidney cancer	1.96e-05	0.000761	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.95e-05	0.000758	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.93e-05	0.000751	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.92e-05	0.000747	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PDHB—kidney cancer	1.92e-05	0.000745	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALDH1A1—kidney cancer	1.91e-05	0.000743	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—POMC—kidney cancer	1.91e-05	0.000743	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.9e-05	0.00074	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—MAPK1—kidney cancer	1.89e-05	0.000736	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—RAF1—kidney cancer	1.86e-05	0.000722	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ACY1—kidney cancer	1.84e-05	0.000713	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PGK1—kidney cancer	1.83e-05	0.000713	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC5A3—kidney cancer	1.83e-05	0.000713	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CCBL1—kidney cancer	1.8e-05	0.000701	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—LDHB—kidney cancer	1.8e-05	0.000699	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.77e-05	0.000687	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—MAPK1—kidney cancer	1.74e-05	0.000678	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.66e-05	0.000647	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.63e-05	0.000634	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—MAPK1—kidney cancer	1.59e-05	0.00062	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.58e-05	0.000614	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.57e-05	0.000608	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PPAT—kidney cancer	1.56e-05	0.000607	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GLIPR1—kidney cancer	1.56e-05	0.000607	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PDHB—kidney cancer	1.56e-05	0.000606	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CA9—kidney cancer	1.56e-05	0.000606	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.56e-05	0.000605	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—POMC—kidney cancer	1.56e-05	0.000605	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—MAPK1—kidney cancer	1.55e-05	0.000602	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.54e-05	0.0006	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.53e-05	0.000594	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.52e-05	0.000592	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—MAPK1—kidney cancer	1.52e-05	0.000591	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—MAPK1—kidney cancer	1.5e-05	0.000581	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.49e-05	0.000577	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CCBL1—kidney cancer	1.47e-05	0.00057	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—MAPK1—kidney cancer	1.46e-05	0.000567	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—FH—kidney cancer	1.45e-05	0.000565	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—APRT—kidney cancer	1.45e-05	0.000565	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.45e-05	0.000564	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.43e-05	0.000556	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.42e-05	0.000552	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.38e-05	0.000535	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	1.37e-05	0.000531	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GPC3—kidney cancer	1.37e-05	0.000531	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.36e-05	0.000527	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CA2—kidney cancer	1.33e-05	0.000516	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.33e-05	0.000516	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CRABP1—kidney cancer	1.33e-05	0.000515	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALAD—kidney cancer	1.3e-05	0.000503	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—MAPK1—kidney cancer	1.27e-05	0.000496	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PPAT—kidney cancer	1.27e-05	0.000494	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.27e-05	0.000494	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.26e-05	0.000491	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.26e-05	0.000488	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.25e-05	0.000486	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.24e-05	0.000483	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.24e-05	0.00048	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ITPR2—kidney cancer	1.23e-05	0.000479	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.21e-05	0.000472	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ACY1—kidney cancer	1.21e-05	0.00047	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.19e-05	0.000464	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PGK1—kidney cancer	1.18e-05	0.00046	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.18e-05	0.00046	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—FH—kidney cancer	1.18e-05	0.00046	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—APRT—kidney cancer	1.18e-05	0.00046	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.17e-05	0.000456	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—LDHB—kidney cancer	1.16e-05	0.000451	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.16e-05	0.000449	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.14e-05	0.000444	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.14e-05	0.000442	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTT1—kidney cancer	1.12e-05	0.000437	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ACHE—kidney cancer	1.12e-05	0.000437	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GPC3—kidney cancer	1.11e-05	0.000432	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CA2—kidney cancer	1.08e-05	0.00042	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SCARB1—kidney cancer	1.06e-05	0.000414	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALAD—kidney cancer	1.05e-05	0.00041	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PSMD7—kidney cancer	1.03e-05	0.000401	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PDHB—kidney cancer	1.03e-05	0.0004	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.03e-05	0.0004	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.03e-05	0.000399	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CA9—kidney cancer	1.01e-05	0.000391	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.01e-05	0.000391	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	9.99e-06	0.000388	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.84e-06	0.000383	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—BCHE—kidney cancer	9.79e-06	0.000381	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CCBL1—kidney cancer	9.68e-06	0.000376	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC5A5—kidney cancer	9.67e-06	0.000376	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PGK1—kidney cancer	9.64e-06	0.000375	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC5A3—kidney cancer	9.64e-06	0.000375	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—LDHB—kidney cancer	9.45e-06	0.000367	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC2A1—kidney cancer	9.34e-06	0.000363	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.06e-06	0.000352	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CRABP1—kidney cancer	8.56e-06	0.000333	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PPAT—kidney cancer	8.39e-06	0.000326	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.39e-06	0.000326	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CA9—kidney cancer	8.2e-06	0.000319	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.01e-06	0.000311	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ITPR2—kidney cancer	7.96e-06	0.000309	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.9e-06	0.000307	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—APRT—kidney cancer	7.8e-06	0.000303	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—FH—kidney cancer	7.8e-06	0.000303	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—kidney cancer	7.79e-06	0.000303	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ABCB1—kidney cancer	7.37e-06	0.000287	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.34e-06	0.000285	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPC3—kidney cancer	7.33e-06	0.000285	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ACHE—kidney cancer	7.26e-06	0.000282	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTT1—kidney cancer	7.26e-06	0.000282	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTM1—kidney cancer	7.16e-06	0.000278	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CA2—kidney cancer	7.13e-06	0.000277	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CRABP1—kidney cancer	6.97e-06	0.000271	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALAD—kidney cancer	6.95e-06	0.00027	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SCARB1—kidney cancer	6.87e-06	0.000267	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS1—kidney cancer	6.8e-06	0.000264	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP1A1—kidney cancer	6.79e-06	0.000264	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.78e-06	0.000264	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PSMD7—kidney cancer	6.67e-06	0.000259	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.63e-06	0.000258	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ITPR2—kidney cancer	6.48e-06	0.000252	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PGK1—kidney cancer	6.36e-06	0.000247	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.36e-06	0.000247	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—BCHE—kidney cancer	6.32e-06	0.000246	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC5A5—kidney cancer	6.25e-06	0.000243	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—LDHB—kidney cancer	6.23e-06	0.000242	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC2A1—kidney cancer	6.03e-06	0.000234	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.97e-06	0.000232	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTT1—kidney cancer	5.91e-06	0.00023	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ACHE—kidney cancer	5.91e-06	0.00023	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.85e-06	0.000228	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SCARB1—kidney cancer	5.59e-06	0.000217	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.58e-06	0.000217	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS1—kidney cancer	5.54e-06	0.000215	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PSMD7—kidney cancer	5.43e-06	0.000211	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CA9—kidney cancer	5.41e-06	0.00021	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—BCHE—kidney cancer	5.15e-06	0.0002	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.11e-06	0.000198	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC5A5—kidney cancer	5.08e-06	0.000198	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—POMC—kidney cancer	5.06e-06	0.000197	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—kidney cancer	5.03e-06	0.000196	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.91e-06	0.000191	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.76e-06	0.000185	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ABCB1—kidney cancer	4.76e-06	0.000185	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTM1—kidney cancer	4.62e-06	0.00018	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CRABP1—kidney cancer	4.6e-06	0.000179	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP1A1—kidney cancer	4.38e-06	0.00017	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ITPR2—kidney cancer	4.27e-06	0.000166	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.16e-06	0.000161	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—kidney cancer	4.1e-06	0.000159	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTGS2—kidney cancer	4.04e-06	0.000157	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTT1—kidney cancer	3.9e-06	0.000151	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ACHE—kidney cancer	3.9e-06	0.000151	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCB1—kidney cancer	3.88e-06	0.000151	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTM1—kidney cancer	3.76e-06	0.000146	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SCARB1—kidney cancer	3.69e-06	0.000143	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS1—kidney cancer	3.65e-06	0.000142	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.6e-06	0.00014	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PSMD7—kidney cancer	3.58e-06	0.000139	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.57e-06	0.000139	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTEN—kidney cancer	3.52e-06	0.000137	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—BCHE—kidney cancer	3.39e-06	0.000132	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.35e-06	0.00013	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—POMC—kidney cancer	3.27e-06	0.000127	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.24e-06	0.000126	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.93e-06	0.000114	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—kidney cancer	2.7e-06	0.000105	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—POMC—kidney cancer	2.66e-06	0.000103	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS2—kidney cancer	2.61e-06	0.000101	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.56e-06	9.94e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CA—kidney cancer	2.48e-06	9.65e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.48e-06	9.65e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.35e-06	9.15e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTEN—kidney cancer	2.27e-06	8.84e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS2—kidney cancer	2.12e-06	8.25e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTEN—kidney cancer	1.85e-06	7.19e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—POMC—kidney cancer	1.75e-06	6.82e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.6e-06	6.23e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.4e-06	5.44e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.31e-06	5.07e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTEN—kidney cancer	1.22e-06	4.74e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.61e-07	3.35e-05	CbGpPWpGaD
